ETIVF yields 7535.80% · PFE yields 6.13%● Live data
📍 ETIVF pulled ahead of the other in Year 1
Combined, ETIVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ETIVF + PFE for your $10,000?
Unbound Group plc, formerly known as Electra Private Equity PLC, specializes in growth capital, buyouts, recapitalization, control buyouts, PIPEs, middle market investments. It invests across all sectors and is not sector specific. The fund seeks to invest in companies based in the Continental Europe, United States and principally in Western Europe, with the majority of investments made in the United Kingdom. It typically invests between £40 million ($49.79 million) and £150 million ($180.73 million). It also co-invests £30 million ($37.35 million) to £100 million ($124.49 million) in minority positions in UK or International companies, alongside founders, other private equity firms, corporates or the public markets. It makes both minority and majority investments. The fund structures its investments through equity, senior equity, and convertible and mezzanine debt. It invests directly from its balance sheet.
Full ETIVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.